Portfolio Archive - Page 19 of 60 - Bryan, Garnier & Co

Bryan, Garnier & Co acts as Joint Bookrunner on Swedish Stirling's SEK 225 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 114 million Publicly Marketed Follow-on Offering

Bryan, Garnier & Co advises Halma on its acquisition of PeriGen

Bryan, Garnier & Co acts as Joint Bookrunner to Valneva on its USD 108 million Nasdaq Initial Public Offering

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Laboratoires Majorelle on the sale of a majority stake to EW Healthcare Partners

Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero

Bryan, Garnier & Co acts as Advisor to the Shareholders of Advania on its majority sale to Goldman Sachs funds

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 100.4 million Marketed Follow-on Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 550 million Initial Public Offering

GenSight_2021_website_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }